Related Experiment Video
Updated: Jul 26, 2025

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Photodynamic immunotherapy using ADU-S100-modified nanoparticles to treat triple-negative breast cancer
Tong Ge1, Wenshu Ge2, Ludan Zhang2
1Department of Immunology, Key Laboratory of Immune Microenvironment & Disease of the Educational Ministry of China, Tianjin Key Laboratory of Cellular & Molecular Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, 300070, China.
Abstract:
Aim: STING agonists in immunotherapy show great promise and are currently in clinical trials. Combinations of STING agonists with other therapies remain underexplored. This study aimed to combine STING agonist-mediated immunotherapy with photodynamic therapy to treat breast cancer. Methods: STING agonist (ADU-S100)-functionalized porphyrin-based nanoparticles (NP-AS) were prepared and their antitumor properties in terms of cell apoptosis/necrosis and immune activation in triple-negative breast cancer were evaluated. Results: NP-AS induced tumor cell apoptosis/necrosis, activated the innate immune response and exhibited useful antitumor effects. Conclusion: NP-AS effectively treated breast cancer.

